Particle.news

Download on the App Store

NIH Study Finds Taurine Levels Poor Biomarker for Aging

Longitudinal tracking of taurine in humans, monkeys and mice revealed no consistent decline with age, prompting a reassessment of its value in aging research.

Energy drinks for sale in a supermarket.
© HandmadePictures via Shutterstock
Image

Overview

  • NIH researchers measured taurine in blood samples from participants in the Baltimore Longitudinal Study of Aging, rhesus monkeys and mice and found levels often increased or stayed constant over decades.
  • Correlations between circulating taurine and health metrics such as muscle strength and body weight were inconsistent across sexes, species and age groups, undercutting its marker potential.
  • The study’s longitudinal, cross-species design overturns earlier cross-sectional findings that had linked taurine decline to aging, highlighting variability as a key challenge.
  • Investigators warn that anti-aging claims for taurine supplements lack support from human trials and should not guide consumer use without clinical validation.
  • A randomized clinical trial led by Vijay Yadav at Rutgers is now testing whether taurine supplementation improves health and fitness in middle-aged adults, with results due by late 2025.